ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

UPDATE - Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction.

The acquisition looks to address a critical challenge for healthcare providers, where the proliferation of connected medical devices has created a vast and unprotected attack surface. These specialized assets, essential to patient care, have historically been invisible to traditional security tools, creating significant risk to both patient safety and hospital operations.

“Hospitals have been operating with a massive digital security blind spot,” said Dean Sysman, co-founder and CEO, Axonius. “The very devices essential for patient care, from infusion pumps to MRI machines, have been completely invisible to cybersecurity teams, creating a dangerous, unprotected attack surface. This acquisition will help end that.”

Sysman added, “By integrating Cynerio’s deep clinical expertise with Axonius asset intelligence, we can offer healthcare providers what they’ve been asking for: a single source of truth capable of securing their entire clinical environment.”

“In today’s healthcare environments, risk doesn’t respect the boundaries between clinical and enterprise systems. The combination of Cynerio's specialized medical device context with Axonius' foundational asset intelligence addresses this challenge directly," said Rasu Shrestha, MD, MBA, EVP and Chief Innovation and Commercialization Officer at Advocate Health, and Chairman of the Board at Cynerio. "It provides the holistic visibility required to manage the entire connected attack surface, enabling healthcare organizations to build more resilient security programs. This is a vital step forward in helping ensure technology can securely and effectively support the core mission of patient care.”

Axonius Acquires Cynerio to Target Healthcare Market

Today’s news represents a significant shift in the healthcare cybersecurity landscape. The acquisition was driven by a shared understanding that securing medical devices in a silo is no longer sufficient. Both companies recognized a growing customer demand for a single, unified platform to manage and secure the entire clinical environment—from traditional IT infrastructure to connected medical devices. By combining Axonius’ asset intelligence platform with Cynerio’s deep medical device expertise, the company is positioned to meet the immediate needs of hospitals while setting the foundation for broader Cyber-Physical Systems (CPS) security.

As part of the acquisition, Cynerio co-founder and CEO, Leon Lerman, will join Axonius as senior vice president. Co-founder Daniel Brodie will join the Office of the CTO. The Cynerio team joins Axonius to accelerate the company’s expansion into the healthcare market. Additional terms of the transaction were not disclosed.

Read more about “The Hidden Side of Healthcare: Why We're Acquiring Cynerio” in a blog post by Dean Sysman, co-founder and CEO, Axonius.

About Cynerio:
Cynerio has one simple goal—to secure every medical device in healthcare environments. With capabilities ranging from microsegmentation and improved device insight to identifying exposed ePHI and stopping ransomware, Cynerio provides the technology and expertise needed to protect hospitals from a variety of cyberattacks.

About Axonius:
Axonius transforms asset intelligence into intelligent action. With the Axonius Asset Cloud, customers preemptively tackle high-risk and hard-to-spot threat exposures, misconfigurations, and overspending. The integrated platform brings together data from every system in an organization’s IT infrastructure to optimize mission-critical risk, performance, and cost measures via actionable intelligence.

Covering cyber assets, software, SaaS applications, identities, vulnerabilities, infrastructure, and more, Axonius is the one place to go for Security, IT, and GRC teams to continuously drive actionability across the organization. Cited as one of the fastest-growing cybersecurity startups, with accolades from CNBC, Forbes, and Fortune, Axonius supports millions of assets for leading customers across industries and around the world.

Bring truth to action with Axonius. Learn more at www.axonius.com.

Media Contact: press@axonius.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7039f767-cc55-4904-9fe9-0d99e7b718a4


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.